The Mirken Family Clinical Neuroscience Institute   

The Mirken Family Clinical Neuroscience Institute was established in 2013 through a generous gift from Mount Sinai Health System Trustee Emeritus Alan Mirken. The Institute serves to coordinate and unite the clinical neuroscience activities across the entire health system and to foster clinical and translational research partnerships.

One of the Institute’s first research projects explores using deep brain stimulation to treat patients with Parkinson's disease, dystonia, and psychiatric illnesses. The research team includes physicians and scientists from throughout the Mount Sinai Health System specializing in neurology, neurosurgery, neuroimaging, neurophysiology, and neurogenetics.

The Institute will also focus on investigating, among other topics, the genetic risk factors that contribute to the development and progression of neurological diseases. As part of this research, Institute scientists will work to identify biomarkers and potential treatment targets.